GT Biopharma, Inc. 10-K Cybersecurity GRC - 2024-03-26

Page last updated on April 11, 2024

GT Biopharma, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-26 17:00:40 EDT.

Filings

10-K filed on 2024-03-26

GT Biopharma, Inc. filed an 10-K at 2024-03-26 17:00:40 EDT
Accession Number: 0001493152-24-011332

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C. CYBERSECURITY [Cybersecurity is an important aspect of our business operations, and we are committed to protecting our systems, data, and the information of our clients and stakeholders. We recognize that cybersecurity threats are constantly evolving and that maintaining robust security measures is an ongoing process. Below is an overview of our cybersecurity risk management and the measures we have in place: Governance and Oversight : Our Board of Directors and senior management are actively involved in overseeing our cybersecurity policies and practices and managing those responsible for coordinating and implementing cybersecurity initiatives across the organization. Risk Assessment and Management : We conduct risk assessments to identify potential cybersecurity threats and vulnerabilities. This includes evaluating the likelihood and potential impact of various threats, such as data breaches, malware attacks, and insider threats. Based on these risk assessments, we develop and implement risk management strategies to mitigate identified risks. Information Security Policies and Procedures : We have established information security policies and procedures that govern the use, protection, and handling of sensitive information. These policies cover areas such as data encryption, access controls, password management, incident response, and employee training. Network and Infrastructure Security : We employ a range of technical measures to secure our network and infrastructure, including firewalls, intrusion detection and prevention systems, and vulnerability assessments. We also use encryption to protect data both in transit and at rest. Employee Training and Awareness : We provide cybersecurity training to employees to raise awareness of the latest threats and best practices for protecting sensitive information. This includes training on how to recognize phishing attempts, handling secure data, and reporting security incidents. Third-Party Risk Management : We assess the cybersecurity practices of our third-party vendors and service providers, including conducting due diligence on vendors before engaging their services and monitoring their compliance with our security requirements. Compliance and Reporting : We comply with all applicable laws and regulations related to cybersecurity, including data protection and privacy laws. While we believe that our current cybersecurity measures are robust, we recognize that the cybersecurity landscape is constantly evolving, and we remain vigilant in monitoring and adapting our practices to address emerging threats. We are committed to maintaining the confidentiality, integrity, and availability of our systems and data and to protecting the interests of our clients and stakeholders. ]


Company Information

NameGT Biopharma, Inc.
CIK0000109657
SIC DescriptionPharmaceutical Preparations
TickerGTBP - Nasdaq
Website
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30